Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Interim Results of the CMML scrna-seq atlas: GMP skewing is independently associated with overall survival in CMML.

Blood (2025) 146 (Supplement 1): 3840.

https://doi.org/10.1182/blood-2025-3840

Published: 2025

Journal Articles

Investigating the clonal and biological underpinnings of systemic mastocytosis with an associated hematological neoplasm

Nana Adjoa Ben-Crentsil, Somedeb Ball, Hannah Newman, Christopher Ryder, Surendra Neupane, Anthony Hunter, Yu-Hung Wang, Kiran Batta, Kristian Gurashi, Traci Kruer, Maria Balasis, Ariel Quintana, Rami Komrokji, David Sallman, Andrew Kuykendall, Tracy George, Daniel Wiseman, Eric Padron

Blood (2025) 146 (Supplement 1): 3763.

https://doi.org/10.1182/blood-2025-3763

Published: 2025

Journal Articles

Ofirnoflast, a novel inflammasome inhibitor, rewires transcriptional programs and shows clinical and preclinical efficacy in myeloid neoplasms

Blood (2025) 146 (Supplement 1): 323.

https://doi.org/10.1182/blood-2025-323

Published: 2025

Journal Articles

Interim Results of the CMML intercept study: A prospective observational study to evaluate the role of acute inflammation in CMML disease progression

Blood (2025) 146 (Supplement 1): 788.

https://doi.org/10.1182/blood-2025-788

Published: 2025

Journal Articles

Impact of clonal hematopoiesis on hematologic recovery and outcomes following tumor-infiltrating lymphocyte therapy

Zhuoer Xie, Surendra Neupane, Joshua Traina, Amond Sarnaik, Shari Pilon-Thomas, Patrick Innamarato, Doris Hansen, Nancy Gillis, David Sallman, Rami Komrokji, Jeffrey Lancet, Lilit Karapetyan, John Mullinax, Eric Padron

Blood (2025) 146 (Supplement 1): 5932.

https://doi.org/10.1182/blood-2025-5932

Published: 2025

Journal Articles

NOXA modulates tipifarnib sensitivity in myeloid leukemia cells.

Traci Kruer, Lei Sun, Ariel Quintana, Meghan Ferrall-Fairbanks, Hannah Newman, Shengyan Xiang, Maria Balasis, Surendra Neupane, Onyee Chan, David Sallman, Rami Komrokji, Jeffrey Lancet, Said Sebti, Eric Padron

Blood (2025) 146 (Supplement 1): 6956.

https://doi.org/10.1182/blood-2025-6956

Published: 2025

Journal Articles

XPO1 drives resistance to eprenetapopt and azacitidine and can be targeted in TP53 -mutated myeloid malignancies

Blood (2025) 146 (18): 2244–2258.

https://doi.org/10.1182/blood.2025028803

Published: 2025

Includes: Supplemental data

Journal Articles

Synchronous Dual Hematologic Neoplasms of Myeloid and Lymphoid Lineage Are of Common Clonal Origin

Blood (2024) 144 (Supplement 1): 4578.

https://doi.org/10.1182/blood-2024-210599

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Date

Availability

Interim Results of the CMML scrna-seq atlas: GMP skewing is independently associated with overall survival in CMML.

Investigating the clonal and biological underpinnings of systemic mastocytosis with an associated hematological neoplasm

Ofirnoflast, a novel inflammasome inhibitor, rewires transcriptional programs and shows clinical and preclinical efficacy in myeloid neoplasms

Interim Results of the CMML intercept study: A prospective observational study to evaluate the role of acute inflammation in CMML disease progression

Impact of clonal hematopoiesis on hematologic recovery and outcomes following tumor-infiltrating lymphocyte therapy

NOXA modulates tipifarnib sensitivity in myeloid leukemia cells.

XPO1 drives resistance to eprenetapopt and azacitidine and can be targeted in TP53 -mutated myeloid malignancies

Synchronous Dual Hematologic Neoplasms of Myeloid and Lymphoid Lineage Are of Common Clonal Origin

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only